Discontinued — last reported Q4 '20
ATI Business Sale Proceeds decreased by 71.4% to $1.60M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2022 to FY 2025), Business Sale Proceeds shows an upward trend with a 845.2% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.00M | $100.00K | $75.00K | $75.00K | $75.00K | $75.00K | -$75.00K | -$75.00K | -$75.00K | -$75.00K | $0.00 | $48.00M | $0.00 | $2.00M | $19.20M | $5.60M | $1.60M |
| QoQ Change | — | -99.8% | -25.0% | +0.0% | +0.0% | +0.0% | -200.0% | +0.0% | +0.0% | +0.0% | +100.0% | — | -100.0% | — | +860.0% | -70.8% | -71.4% |
| YoY Change | — | — | — | — | -99.9% | -25.0% | -200.0% | -200.0% | -200.0% | -200.0% | +100.0% | >999% | — | — | — | -88.3% | — |